We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-4.12%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$6.57B
AUM Growth
-$731M
Cap. Flow
-$225M
Cap. Flow %
-3.42%
Top 10 Hldgs %
32.2%
Holding
361
New
20
Increased
74
Reduced
159
Closed
103

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$76.5M
2
DDOG icon
Datadog
DDOG
+$70.6M
3
PI icon
Impinj
PI
+$64.7M
4
AVID
Avid Technology Inc
AVID
+$24.3M
5
DOCU
DocuSign
DOCU
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 32.7%
2 Consumer Discretionary 19.91%
3 Healthcare 15.72%
4 Communication Services 11.32%
5 Industrials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETNB
201
DELISTED
89bio
ETNB
$1.25M 0.02%
81,207
+244
+0.3% +$4.1K
STKS icon
202
The ONE Group
STKS
$50.4M
$1.21M 0.02%
220,127
-102,510
-32% -$696K
EWCZ
203
DELISTED
European Wax Center
EWCZ
$1.19M 0.02%
73,736
-3,543
-5% -$63.8K
UBER icon
204
Uber
UBER
$146B
$1.17M 0.02%
25,465
+21
+0.1% +$959
KYMR icon
205
Kymera Therapeutics
KYMR
$9.33B
$1.14M 0.02%
81,865
-6,867
-8% -$138K
RLAY icon
206
Relay Therapeutics
RLAY
$4.14B
$1.11M 0.02%
132,210
-53,892
-29% -$580K
IAUX
207
i-80 Gold Corp
IAUX
$1.45B
$1.1M 0.02%
716,171
-4,194
-0.6% -$8.22K
BWIN
208
Baldwin Insurance Group
BWIN
$3.13B
$1.08M 0.02%
46,400
-15,450
-25% -$386K
HIMS icon
209
Hims & Hers Health
HIMS
$6.61B
$1.06M 0.02%
169,125
-949
-0.6% -$7.06K
BBIO icon
210
BridgeBio Pharma
BBIO
$13.7B
$1.06M 0.02%
40,126
+4,570
+13% +$130K
RELY icon
211
Remitly
RELY
$4.64B
$1.01M 0.02%
39,954
+1,903
+5% +$42.9K
PEN icon
212
Penumbra
PEN
$12.6B
$992K 0.02%
4,099
-39
-0.9% -$10.8K
KRYS icon
213
Krystal Biotech
KRYS
$9.91B
$873K 0.01%
7,528
+25
+0.3% +$3.05K
PCVX icon
214
Vaxcyte
PCVX
$8.77B
$872K 0.01%
17,106
+84
+0.5% +$4.14K
SIBN icon
215
SI-BONE Inc
SIBN
$829M
$871K 0.01%
40,984
-81
-0.2% -$1.88K
PI icon
216
Impinj
PI
$5.24B
$865K 0.01%
15,717
-953,083
-98% -$64.7M
MLTX icon
217
MoonLake Immunotherapeutics
MLTX
$1.04B
$853K 0.01%
14,959
-88
-0.6% -$4.86K
WOLF icon
218
Wolfspeed
WOLF
$1.26B
$786K 0.01%
20,632
-41,101
-67% -$2.15M
CYTK icon
219
Cytokinetics
CYTK
$9.66B
$782K 0.01%
26,533
+69
+0.3% +$2.3K
SONO icon
220
Sonos
SONO
$1.79B
$725K 0.01%
56,121
+125
+0.2% +$1.85K
ETSY icon
221
Etsy
ETSY
$6.78B
$668K 0.01%
10,349
-36,557
-78% -$2.88M
BHVN icon
222
Biohaven
BHVN
$1.84B
$664K 0.01%
25,530
-65
-0.3% -$1.35K
AVGO icon
223
Broadcom
AVGO
$1.63T
$628K 0.01%
7,560
+3,670
+94% +$318K
GDRX icon
224
GoodRx Holdings
GDRX
$1.2B
$608K 0.01%
+108,061
New +$720K
RUN icon
225
Sunrun
RUN
$2.02B
$588K 0.01%
+46,786
New +$769K

Similar funds

Gilder Gagnon Howe & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Gilder Gagnon Howe & Co held 361 positions worth $6.57B, down 10% from $7.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $225M in Q3 2023, closing 103 positions and reducing 159 holdings. Its most notable exit was Avid Technology Inc, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Knife River worth $37.9M.

  • Gilder Gagnon Howe & Co's largest Q3 2023 buy was Knife River: 777,114 shares worth $37.9M.
  • Gilder Gagnon Howe & Co added most to Intel in Q3 2023, an estimated $72M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2023 reduction was Tesla, cutting an estimated $76.5M.
  • Gilder Gagnon Howe & Co fully exited Avid Technology Inc in Q3 2023, selling an estimated $24.3M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 32% of its $6.57B portfolio in Q3 2023.
  • Gilder Gagnon Howe & Co opened 20 new positions and closed 103 in Q3 2023.
  • Gilder Gagnon Howe & Co's portfolio value fell 10% quarter-over-quarter to $6.57B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2023, filed 14 Nov 2023.